Compounds > propyl pyrazinoate
Page last updated: 2024-08-25

propyl pyrazinoate and pyrazinamide

propyl pyrazinoate has been researched along with pyrazinamide in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, TS; Cynamon, MH; Gimi, RH; Klemens, SP; Welch, JT1
Arai, M; Jacobs, WR; Vilchèze, C; Welch, JT; Zimhony, O1
Chung, WJ; Jacobs, WR; Ngo, SC; Sayahi, H; Welch, JT; Zimhony, O1
Cynamon, MH; Speirs, RJ; Welch, JT1
Baughn, AD; Dillon, NA; Peterson, ND; Rosen, BC1
Braunstein, MS; Durham, PG; Hickey, AJ; Welch, JT; Young, EF1

Other Studies

6 other study(ies) available for propyl pyrazinoate and pyrazinamide

ArticleYear
Antimycobacterial activity of a series of pyrazinoic acid esters.
    Journal of medicinal chemistry, 1992, Apr-03, Volume: 35, Issue:7

    Topics: Animals; Antitubercular Agents; Esters; Hydrogen-Ion Concentration; Mice; Mycobacterium; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrazinamide

1992
Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Bacterial Proteins; Fatty Acid Synthases; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Structure-Activity Relationship; Tuberculosis

2007
Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Bacterial Proteins; Cell-Free System; Fatty Acid Synthases; Humans; Inhibitory Concentration 50; Kinetics; Mass Spectrometry; Molecular Structure; Mycobacterium tuberculosis; NADP; Oxidation-Reduction; Pyrazinamide; Reproducibility of Results; Substrate Specificity

2007
Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:6

    Topics: Amidohydrolases; Antibiotics, Antitubercular; Drug Resistance, Microbial; Esterases; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Niacin; Pyrazinamide; Structure-Activity Relationship

1995
Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12

    Topics: Antitubercular Agents; beta-Alanine; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Niacinamide; Pantetheine; Pantothenic Acid; Pyrazinamide

2014
A dry powder combination of pyrazinoic acid and its n-propyl ester for aerosol administration to animals.
    International journal of pharmaceutics, 2016, Dec-05, Volume: 514, Issue:2

    Topics: Administration, Inhalation; Administration, Intranasal; Animals; Drug Combinations; Drug Compounding; Dry Powder Inhalers; Particle Size; Powders; Pyrazinamide

2016